Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-01-06 @ 9:45 AM
Study NCT ID:
NCT04654403
Status:
UNKNOWN
Last Update Posted:
2021-08-23
First Post:
2020-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization: